MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2017 International Congress

    A novel cause for unpredictable response to levodopa

    J. Staisch, G. Bakis, J. Nutt (Portland, OR, USA)

    Objective: [To describe a novel cause for unpredictable response to levodopa] Background: A fluctuating response to levodopa is common in advanced Parkinson’s disease and can…
  • 2017 International Congress

    Neuroticism and depression is associated with impulse control disorder in Parkinson’s disease: a controlled study

    N. Titova, N. Sotnikova, E. Katunina (Moscow, Russian Federation)

    Objective: Cross-sectional assessment of personality trait, impulsivity, depression and anxiety collected prospectively in Parkinson’s disease (PD) with impulse control disorders (PD-ICD) compared to a matched…
  • 2017 International Congress

    Sleep architecture in Parkinson´s disease and Parkinson’s disease associated dementia

    L. Sousa, I. Laranjinha, J. Lopes, J. Ramalheira, A.M. da Silva, A.B. Lima, M. Magalhães (Porto, Portugal)

    Objective: To evaluate the differences in early sleep architecture between patients with Parkinson’s disease (PD) and Parkinson’s disease associated dementia (PDD). Background: Disorders of sleep…
  • 2017 International Congress

    Parkinson’s disease in untreated Gaucher patients is associated with reduced glucosylsphingosine (Lyso-Gb1) serum levels

    D. Arkadir, T. Dinur, A. Rolfs, A. Zimran (Jerusalem, Israel)

    Objective: To assess the role of glycosphingolipids in increased risk of Parkinson's disease (PD) in patients with Gaucher disease (GD). Background: Patients with GD are…
  • 2017 International Congress

    The identification of molecular-genetic background of familial atypical parkinsonism in “Hornacko”, a specific region of the south-eastern Moravia, Czech Republic.

    K. Mensikova, R. Vodicka, K. Kolarikova, T. Bartonikova, P. Kanovsky (Olomouc, Czech Republic)

    Objective: To assess the genetic background in the pedigrees with identified autosomal-dominant inheritance of parkinsonism. Background: Increased prevalence of parkinsonism with cognitive deterioration was detected…
  • 2017 International Congress

    Capgras syndrome in advanced Parkinson disease

    C. Groth, A. Pusso, D. Huss, S. Sperling, B. Shah, M. Harrison, W.J. Elias, G.F. Wooten, M. Barrett (Charlottesville, VA, USA)

    Objective: The aims of this study were to investigate the frequency of Capgras syndrome in Parkinson's disease patients who have undergone Deep Brain Stimulation (DBS)…
  • 2017 International Congress

    Serum uric acid levels and freezing of gait in Parkinson’s disease

    R. Ou, B. Cao, Q. Wei, Y. Hou, Y. Xu, W. Song, B. Zhao (Chengdu, China)

    Objective: To investigate the relationship between serum Uric acid (UA) levels and freezing of gait (FOG) in Parkinson’s disease (PD). Background: UA is a natural…
  • 2017 International Congress

    Differential Item Functioning in the Unified Dyskinesia Rating Scale (UDysRS)

    S. Luo, G. Stebbins, Y. Liu, C. Goetz (Houston, TX, USA)

    Objective: Test if differential item functioning (DIF) due to gender, age, race/ethnicity or education level is present in UDysRS items.    Background: Testing a rating…
  • 2017 International Congress

    Self Perception of Dysphagia in Parkinson Disease

    A. Silbergleit, C. Sidiropoulos, R. Konnai, L. Schultz, A. Kitowski, P. LeWitt (West Bloomfield, MI, USA)

    Objective: To determine when individuals with Parkinson disease (PD) perceive impairment of swallowing as it relates to time since diagnosis.  Background: Dysphagia, and particularly silent…
  • 2017 International Congress

    Study Design of an Efficacy and Safety Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial of APL-130277 in the Treatment of OFF Episodes (CTH-300)

    C.W. Olanow, E. Pappert, P. Gardzinski, B. Dzyngel, A. Agro (New York, NY, USA)

    Objective: To review the unique features of the ongoing Phase 3 trial for APL-130277.  Background: Patients with Parkinson’s disease (PD) frequently develop problematic OFF episodes…
  • « Previous Page
  • 1
  • …
  • 305
  • 306
  • 307
  • 308
  • 309
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
    • An atypical and interesting feature of Parkinson´s disease
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley